FDA Recommends Warning on Tamiflu Label
14th Nov 2006, 18:50 GMT
US health authorities have recommended adding a new warning to the label of Roche's influenza drug Tamiflu after reports of psychiatric side effects from patients taking the drug. The FDA said they reviewed 103 psychiatric reports including suicidal behaviour from August 2005 to July 2006.
FDA Recommends Warning on Tamiflu Label related news:
- FDA recommends warning on Tamiflu label — Pharmaceutical Business Review Latest News
- FDA Suggests New Tamiflu Warning — WSJ.com: What's News US
- FDA Posts New Tamiflu Warning — WebMD Health Headlines
- FDA wants warning for Tamiflu drug label — floridatoday.com - Local News
- Tamiflu label gets 'abnormal behavior' warning — baltimoresun.com - nation/world
- FDA adds 'abnormal behavior' warning for Tamiflu — azcentral.com | business
- FDA adds 'abnormal behavior' warning for Tamiflu label — CNN.com Recently Published/Updated
- FDA proposes "abnormal behavior" warning for Tamiflu label — WISTV - Health
- FDA proposes 'abnormal behavior' warning for Tamiflu label — Athens Banner Herald:News
- Warning of psychiatric problems with Tamiflu. — Environmental Health News
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry